Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | AFF4 CL E G H | 27125 | 17869 | ORPHA:444077 | Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 85 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | AGPAT2 CL E G H | 10555 | 325 | OMIM:608594 | Lipodystrophy, congenital generalized, type 1 | . | | | 85 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | AIP CL E G H | 9049 | 358 | ORPHA:963 | Acromegaly | HP:0040283 - Occasional | | | 95 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | AKT2 CL E G H | 208 | 392 | ORPHA:79085 | AKT2-related familial partial lipodystrophy | HP:0040281 - Very frequent | | | 12 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | HP:0040282 - Frequent | | | 404 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | . | | | 404 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 105 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | BSCL2 CL E G H | 26580 | 15832 | OMIM:269700 | Lipodystrophy, congenital generalized, type 2 | . | | | 105 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:363400 | Severe neurodegenerative syndrome with lipodystrophy | HP:0040283 - Occasional | | | 105 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 11 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CAV1 CL E G H | 857 | 1527 | OMIM:612526 | Lipodystrophy, congenital generalized, type 3 | | | | 11 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CAV1 CL E G H | 857 | 1527 | OMIM:606721 | Lipodystrophy, familial partial, type 7 | | | | 11 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 48 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CIDEC CL E G H | 63924 | 24229 | ORPHA:435651 | CIDEC-related familial partial lipodystrophy | HP:0040281 - Very frequent | | | 8 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CIDEC CL E G H | 63924 | 24229 | OMIM:615238 | Lipodystrophy, familial partial, type 5 | . | | | 8 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CLDN1 CL E G H | 9076 | 2032 | ORPHA:59303 | Neonatal ichthyosis-sclerosing cholangitis syndrome | HP:0040283 - Occasional | | | 11 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | COPB1 CL E G H | 1315 | 2231 | OMIM:619255 | BARALLE-MACKEN SYNDROME; BARMACS | | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CUL4B CL E G H | 8450 | 2555 | ORPHA:85293 | X-linked intellectual disability, Cabezas type | HP:0040283 - Occasional | | | 38 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | CYP19A1 CL E G H | 1588 | 2594 | ORPHA:91 | Aromatase deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | ELOVL1 CL E G H | 64834 | 14418 | OMIM:618527 | Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features | . | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | ERF CL E G H | 2077 | 3444 | ORPHA:207 | Crouzon disease | HP:0040283 - Occasional | | | 12 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | ESR1 CL E G H | 2099 | 3467 | OMIM:615363 | Estrogen resistance | . | | | 13 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | ESR1 CL E G H | 2099 | 3467 | ORPHA:785 | Estrogen resistance syndrome | HP:0040282 - Frequent | | | 13 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR2 CL E G H | 2263 | 3689 | OMIM:123790 | Beare-Stevenson cutis gyrata syndrome | . | | | 175 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:207 | Crouzon disease | HP:0040283 - Occasional | | | 175 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:1555 | Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome | HP:0040281 - Very frequent | | | 175 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:15 | Achondroplasia | HP:0040283 - Occasional | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:616482 | Achondroplasia, severe, with developmental delay and acanthosis nigricans | . | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:612247 | Crouzon syndrome with acanthosis nigricans | . | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:93262 | Crouzon syndrome-acanthosis nigricans syndrome | HP:0040281 - Very frequent | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | OMIM:146000 | HYPOCHONDROPLASIA | HP:0040283 - Occasional | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:85165 | Severe achondroplasia-developmental delay-acanthosis nigricans syndrome | HP:0040281 - Very frequent | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:1860 | Thanatophoric dysplasia type 1 | HP:0040283 - Occasional | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:93274 | Thanatophoric dysplasia type 2 | HP:0040283 - Occasional | | | 145 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | GPR101 CL E G H | 83550 | 14963 | ORPHA:963 | Acromegaly | HP:0040283 - Occasional | | | 5 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | GPR101 CL E G H | 83550 | 14963 | OMIM:300942 | Chromosome Xq26.3 duplication syndrome | | | | 5 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | HRAS CL E G H | 3265 | 5173 | ORPHA:3071 | Costello syndrome | HP:0040281 - Very frequent | | | 113 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | HRAS CL E G H | 3265 | 5173 | OMIM:218040 | Costello syndrome | . | | | 113 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | HSD11B1 CL E G H | 3290 | 5208 | OMIM:614662 | Cortisone reductase deficiency 2 | HP:0040283 - Occasional | | | 5 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | INSR CL E G H | 3643 | 6091 | OMIM:246200 | Donohue syndrome | . | | | 229 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | INSR CL E G H | 3643 | 6091 | ORPHA:508 | Leprechaunism | HP:0040282 - Frequent | | | 229 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | INSR CL E G H | 3643 | 6091 | OMIM:262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities | . | | | 229 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | INSR CL E G H | 3643 | 6091 | ORPHA:769 | Rabson-Mendenhall syndrome | HP:0040282 - Frequent | | | 229 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | JUP CL E G H | 3728 | 6207 | ORPHA:34217 | Naxos disease | HP:0040283 - Occasional | | | 222 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | LIPE CL E G H | 3991 | 6621 | ORPHA:435660 | LIPE-related familial partial lipodystrophy | HP:0040281 - Very frequent | | | 7 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | LIPE CL E G H | 3991 | 6621 | OMIM:615980 | Lipodystrophy, familial partial, type 6 | | | | 7 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:280365 | Autosomal semi-dominant severe lipodystrophic laminopathy | HP:0040282 - Frequent | | | 645 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:2348 | Familial partial lipodystrophy, Dunnigan type | HP:0040283 - Occasional | | | 645 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:79084 | Familial partial lipodystrophy, Köbberling type | HP:0040283 - Occasional | | | 645 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | LMNA CL E G H | 4000 | 6636 | OMIM:248370 | Mandibuloacral dysplasia | | | | 645 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | MC4R CL E G H | 4160 | 6932 | ORPHA:71529 | Obesity due to melanocortin 4 receptor deficiency | HP:0040283 - Occasional | | | 54 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PCSK1 CL E G H | 5122 | 8743 | ORPHA:71528 | Obesity due to prohormone convertase I deficiency | HP:0040283 - Occasional | | | 65 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PEX1 CL E G H | 5189 | 8850 | ORPHA:3220 | Deafness-enamel hypoplasia-nail defects syndrome | HP:0040283 - Occasional | | | 169 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PEX6 CL E G H | 5190 | 8859 | ORPHA:3220 | Deafness-enamel hypoplasia-nail defects syndrome | HP:0040283 - Occasional | | | 98 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PKDCC CL E G H | 91461 | 25123 | OMIM:618821 | RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES; RLSDF | | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PLIN1 CL E G H | 5346 | 9076 | OMIM:613877 | Lipodystrophy, familial partial, type 4 | . | | | 19 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PLIN1 CL E G H | 5346 | 9076 | ORPHA:280356 | PLIN1-related familial partial lipodystrophy | HP:0040280 - Obligate | | | 19 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | HP:0040282 - Frequent | | | 138 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | POMC CL E G H | 5443 | 9201 | ORPHA:71526 | Obesity due to pro-opiomelanocortin deficiency | HP:0040283 - Occasional | | | 27 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | . | | | 42 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PSMB4 CL E G H | 5692 | 9541 | OMIM:617591 | Proteasome-Associated autoinflammatory syndrome 3 | . | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PSMB8 CL E G H | 5696 | 9545 | OMIM:256040 | Proteasome-associated autoinflammatory syndrome 1 and digenic forms | | | | 20 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | PSMB9 CL E G H | 5698 | 9546 | OMIM:617591 | Proteasome-Associated autoinflammatory syndrome 3 | . | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | SMARCD2 CL E G H | 6603 | 11107 | OMIM:617475 | SPECIFIC GRANULE DEFICIENCY 2; SGD2 | | | | 3 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | SPINK5 CL E G H | 11005 | 15464 | ORPHA:634 | Netherton syndrome | HP:0040281 - Very frequent | | | 100 | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | TFE3 CL E G H | 7030 | 11752 | OMIM:301066 | INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES; MRXSPF | | | | | | |
HP:0000956 | HP:0000956 | Acanthosis nigricans | 0 | XRCC4 CL E G H | 7518 | 12831 | OMIM:616541 | Short stature, microcephaly, and endocrine dysfunction | . | | | 9 | | |